Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards Lifesciences Corp.

www.edwards.com

Latest From Edwards Lifesciences Corp.

EuroPCR 2018: Real-World TAVR Data Show Consistent Performance With Edwards, Abbott, And Medtronic's Systems

New real-world data on Edward Lifesciences real-world data for its transcatheter aortic valve replacement Sapien 3 valve are among the highlights from the early Hot Line/Late-Breaking Trial sessions at the EuroPCR conference in Paris.

Clinical Trials Innovation

CMS Weighs Whether Volume Requirements Are Needed For TAVR

The US agency will convene advisors this summer to reassess whether hospital and practitioner procedure volume requirements, currently a prerequisite for running a Medicare-covered transcatheter aortic heart valve replacement program, are warranted.

Reimbursement Market Access

Medicare Bonus Payments: CMS Plans To End Three, But Considers Seven New-Tech Add-On Payments For FY 2019

While the US Medicare agency is proposing to end hospital inpatient new-technology add-on payments for Edwards Lifesciences’ and LivaNova’s minimally surgical valves, and for WL Gore's endoprosthesis aneurysm device, it is evaluating possible bonus payments for 7 more devices beginning Oct. 1.

Reimbursement Market Access

SCAI2018: Innovation In Cardiovascular Interventions From The Cath Lab, Incubators, Robotic PCI, Digital Health

This year's annual meeting of the Society for Cardiovascular Angiography and Interventions' Scientific Sessions is expected to draw nearly 2,000 interventional cardiologists worldwide to San Diego for the four-day meeting ending April 28. Among the highlights of scientific sessions was the all-new Innovations in Cardiovascular Interventions and Technology Summit on April 25, hosted in partnership with Innovations in Cardiovascular Interventions (ICI Israel), which focused on evolving technologies and strategies for innovations. This article rounds up the best Tweets posted by Medtech Insight attending #SAIC2018. It includes presentations on how to create true innovation at an incubator and at big companies like Edwards Lifesciences, new products on the market and US FDA evolution toward medical device evaluation.

Cardiovascular Surgical Procedures
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register